110 related articles for article (PubMed ID: 33738081)
1. Computationally-guided design and affinity improvement of a protein binder targeting a specific site on HER2.
Kim TY; Cha JS; Kim H; Choi Y; Cho HS; Kim HS
Comput Struct Biotechnol J; 2021; 19():1325-1334. PubMed ID: 33738081
[TBL] [Abstract][Full Text] [Related]
2. Computer-guided binding mode identification and affinity improvement of an LRR protein binder without structure determination.
Choi Y; Jeong S; Choi JM; Ndong C; Griswold KE; Bailey-Kellogg C; Kim HS
PLoS Comput Biol; 2020 Aug; 16(8):e1008150. PubMed ID: 32866140
[TBL] [Abstract][Full Text] [Related]
3. Modular binder technology by NGS-aided, high-resolution selection in yeast of designed armadillo modules.
Stark Y; Menard F; Jeliazkov JR; Ernst P; Chembath A; Ashraf M; Hine AV; Plückthun A
Proc Natl Acad Sci U S A; 2024 Jul; 121(27):e2318198121. PubMed ID: 38917007
[TBL] [Abstract][Full Text] [Related]
4. Computational epitope binning reveals functional equivalence of sequence-divergent paratopes.
Mahita J; Kim DG; Son S; Choi Y; Kim HS; Bailey-Kellogg C
Comput Struct Biotechnol J; 2022; 20():2169-2180. PubMed ID: 35615020
[TBL] [Abstract][Full Text] [Related]
5. Tracking protein-protein interaction and localization in living cells using a high-affinity molecular binder.
Kim HY; Lee JJ; Kim N; Heo WD; Kim HS
Biochem Biophys Res Commun; 2016 Feb; 470(4):857-63. PubMed ID: 26820537
[TBL] [Abstract][Full Text] [Related]
6. Engineering a Minimal Leucine-rich Repeat IgG-binding Module.
Markou GC; Ohoka A; Sarkar CA
Appl Biochem Biotechnol; 2022 Apr; 194(4):1636-1644. PubMed ID: 34837634
[TBL] [Abstract][Full Text] [Related]
7. Protein binder for affinity purification of human immunoglobulin antibodies.
Heu W; Choi JM; Lee JJ; Jeong S; Kim HS
Anal Chem; 2014 Jun; 86(12):6019-25. PubMed ID: 24877609
[TBL] [Abstract][Full Text] [Related]
8. Prolonged half-life of small-sized therapeutic protein using serum albumin-specific protein binder.
Kim TY; Park JH; Shim HE; Choi DS; Lee DE; Song JJ; Kim HS
J Control Release; 2019 Dec; 315():31-39. PubMed ID: 31654685
[TBL] [Abstract][Full Text] [Related]
9. Grafting of functional motifs onto protein scaffolds identified by PDB screening--an efficient route to design optimizable protein binders.
Tlatli R; Nozach H; Collet G; Beau F; Vera L; Stura E; Dive V; Cuniasse P
FEBS J; 2013 Jan; 280(1):139-59. PubMed ID: 23121732
[TBL] [Abstract][Full Text] [Related]
10. Genetically functionalized ferritin nanoparticles with a high-affinity protein binder for immunoassay and imaging.
Kim JW; Heu W; Jeong S; Kim HS
Anal Chim Acta; 2017 Oct; 988():81-88. PubMed ID: 28916107
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Specific Binder Design by Yeast Surface Display.
Mann JK; Park S
Methods Mol Biol; 2015; 1319():143-54. PubMed ID: 26060073
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition.
Tolmachev V; Tran TA; Rosik D; Sjöberg A; Abrahmsén L; Orlova A
J Nucl Med; 2012 Jun; 53(6):953-60. PubMed ID: 22586147
[TBL] [Abstract][Full Text] [Related]
13. Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping.
Liu X; Taylor RD; Griffin L; Coker SF; Adams R; Ceska T; Shi J; Lawson AD; Baker T
Sci Rep; 2017 Jan; 7():41306. PubMed ID: 28128368
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of Her2 binding-designed ankyrin repeat proteins.
Zahnd C; Pecorari F; Straumann N; Wyler E; Plückthun A
J Biol Chem; 2006 Nov; 281(46):35167-75. PubMed ID: 16963452
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for eliciting a cytotoxic effect in HER2-overexpressing cancer cells via binding to the extracellular domain of HER2.
Jost C; Schilling J; Tamaskovic R; Schwill M; Honegger A; Plückthun A
Structure; 2013 Nov; 21(11):1979-91. PubMed ID: 24095059
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders.
Kawakita Y; Banno H; Ohashi T; Tamura T; Yusa T; Nakayama A; Miki H; Iwata H; Kamiguchi H; Tanaka T; Habuka N; Sogabe S; Ohta Y; Ishikawa T
J Med Chem; 2012 Apr; 55(8):3975-91. PubMed ID: 22439974
[TBL] [Abstract][Full Text] [Related]
17. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.
Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V
J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382
[TBL] [Abstract][Full Text] [Related]
18. A regulatory SH2 domain-targeting protein binder effectively inhibits the activity of Bruton's tyrosine kinase and its drug-resistant variants.
Jeong S; Sohn YK; Choi Y; Park J; Kim HS
Biochem Biophys Res Commun; 2020 May; 526(1):8-13. PubMed ID: 32192770
[TBL] [Abstract][Full Text] [Related]
19. A SPR strategy for high-throughput ligand screenings based on synthetic peptides mimicking a selected subdomain of the target protein: a proof of concept on HER2 receptor.
Monfregola L; Vitale RM; Amodeo P; De Luca S
Bioorg Med Chem; 2009 Oct; 17(19):7015-20. PubMed ID: 19733086
[TBL] [Abstract][Full Text] [Related]
20. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding.
Thomas D; Rozell TG; Liu X; Segaloff DL
Mol Endocrinol; 1996 Jun; 10(6):760-8. PubMed ID: 8776736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
